• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Durable Response to Vismodegib in PTCH1 F1147fs Mutant Relapsed Malignant Pleural Mesothelioma: Implications for Mesothelioma Drug Treatment.

作者信息

Popat Sanjay, Sharma Bhupinder, MacMahon Suzanne, Nicholson Andrew G, Sharma Rajaei K, Schuster Klaus, Lang Lazdunski Loic, Fennell Dean

机构信息

Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.

Section of Clinical Studies, Institute of Cancer Research, London, United Kingdom.

出版信息

JCO Precis Oncol. 2021 Nov;5:39-43. doi: 10.1200/PO.20.00260.

DOI:10.1200/PO.20.00260
PMID:34994590
Abstract
摘要

相似文献

1
Durable Response to Vismodegib in PTCH1 F1147fs Mutant Relapsed Malignant Pleural Mesothelioma: Implications for Mesothelioma Drug Treatment.维莫德吉对PTCH1 F1147fs突变型复发性恶性胸膜间皮瘤的持久反应：对间皮瘤药物治疗的启示
JCO Precis Oncol. 2021 Nov;5:39-43. doi: 10.1200/PO.20.00260.
2
Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib.对一名携带PTCH1突变的转移性成人髓母细胞瘤进行血浆循环肿瘤DNA监测，结果显示维莫德吉具有持久疗效。
Oncologist. 2024 May 3;29(5):377-383. doi: 10.1093/oncolo/oyae026.
3
Conversion surgery for locally advanced malignant pleural mesothelioma.局部晚期恶性胸膜间皮瘤的转化手术。
Gen Thorac Cardiovasc Surg. 2020 Dec;68(12):1547-1550. doi: 10.1007/s11748-020-01329-y. Epub 2020 Mar 12.
4
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.阿柔比星治疗既往治疗的恶性胸膜间皮瘤患者：一项 II 期研究。
Thorac Cancer. 2020 Jul;11(7):1972-1978. doi: 10.1111/1759-7714.13490. Epub 2020 May 28.
5
Complete response is reversible upon vismodegib withdrawal and re-inducible upon vismodegib rechallenge in a patient with locally advanced basal cell carcinoma.在一名局部晚期基底细胞癌患者中，完全缓解在维莫德吉停药后可逆，在维莫德吉再次给药时可再次诱导。
J Eur Acad Dermatol Venereol. 2019 May;33(5):e187-e188. doi: 10.1111/jdv.15428. Epub 2019 Feb 27.
6
Drug hypersensitivity syndrome in a patient receiving vismodegib.一名接受维莫德吉治疗的患者发生药物超敏反应综合征。
J Am Acad Dermatol. 2014 Mar;70(3):e65-6. doi: 10.1016/j.jaad.2013.11.018.
7
Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.用维莫德吉拮抗刺猬信号通路通过影响基质来损害恶性胸膜间皮瘤的体内生长。
Mol Cancer Ther. 2016 May;15(5):1095-105. doi: 10.1158/1535-7163.MCT-15-0583. Epub 2016 Feb 2.
8
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.微 RNA 负载微细胞在复发性恶性胸膜间皮瘤患者中的安全性和活性：首例人体、1 期、开放标签、剂量递增研究。
Lancet Oncol. 2017 Oct;18(10):1386-1396. doi: 10.1016/S1470-2045(17)30621-6. Epub 2017 Sep 1.
9
Secondary Resistance to Vismodegib After Initial Successful Treatment of Extensive Recurrent Periocular Basal Cell Carcinoma with Orbital Invasion.初始成功治疗广泛复发性眼眶侵袭性眼周基底细胞癌后对维莫德吉产生继发性耐药。
Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S68-S70. doi: 10.1097/IOP.0000000000000565.
10
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.达沙替尼治疗下恶性胸膜间皮瘤基因组和 T 细胞受体库异质性的演变。
Clin Cancer Res. 2020 Oct 15;26(20):5477-5486. doi: 10.1158/1078-0432.CCR-20-1767. Epub 2020 Aug 14.

引用本文的文献

1
Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack.临床下一代测序在间皮瘤中的应用：大海捞针
Cancers (Basel). 2023 Dec 6;15(24):5716. doi: 10.3390/cancers15245716.
2
Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology.间皮瘤中初级纤毛表达及刺猬信号通路激活的分析揭示其复杂生物学特性
Cancers (Basel). 2022 Oct 25;14(21):5216. doi: 10.3390/cancers14215216.
3
Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
间皮瘤中的肿瘤免疫微环境与基因改变
Front Oncol. 2021 Jun 23;11:660039. doi: 10.3389/fonc.2021.660039. eCollection 2021.
4
Precision Therapy for Mesothelioma: Feasibility and New Opportunities.间皮瘤的精准治疗：可行性与新机遇
Cancers (Basel). 2021 May 13;13(10):2347. doi: 10.3390/cancers13102347.